About NiKem NiKem was formed in 2001 from GSK's Milan Research Group to offer a range of services from hit generation to preclin
![PDF) Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists | B. Imbimbo - Academia.edu PDF) Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists | B. Imbimbo - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/70636347/mini_magick20210929-16965-3yn7oh.png?1632975076)
PDF) Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists | B. Imbimbo - Academia.edu
Antimetastatic effect of a small molecule vacuolar H -ATPase inhibitor in in vitro and in vivo preclinical studies
![Accelerating the drug-discovery process: new tools and technologies available to medicinal chemists | Future Medicinal Chemistry Accelerating the drug-discovery process: new tools and technologies available to medicinal chemists | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.09.79/asset/images/medium/graphic29.gif)
Accelerating the drug-discovery process: new tools and technologies available to medicinal chemists | Future Medicinal Chemistry
![PDF) Synthesis and Biological Activity of Flurbiprofen Analogues as Selective Inhibitors of Beta-Amyloid1-42 Secretion PDF) Synthesis and Biological Activity of Flurbiprofen Analogues as Selective Inhibitors of Beta-Amyloid1-42 Secretion](https://i1.rgstatic.net/publication/7626103_Synthesis_and_Biological_Activity_of_Flurbiprofen_Analogues_as_Selective_Inhibitors_of_Beta-Amyloid1-42_Secretion/links/5caba20f92851c64bd59da74/largepreview.png)